A Discussion on the Evolution and Future of Healthcare Coverage: Debunking the Myths of Universal Healthcare

Tristen Slamowitz Background: Healthcare coverage is defined as a means for financing a person’s healthcare expenses and is intended to reduce barriers to access, protect individuals from unexpected costs, and promote economic instability. In 2021, 8.3% of people living in the United States, or 27.2 million people, did not have…
Engineering Medicine Healthcare

Repetitive Transcranial Magnetic Stimulation (rTMS) as a Treatment for Major Depressive Disorder (MDD) and Post-Traumatic Stress Disorder (PTSD) in Military Populations

Miles Hill Background: Post traumatic stress disorder (PTSD) and major depressive disorder (MDD) are among the most common psychiatric disorders that affect military service members (SMs) and veterans in the United States. SMs suffering from PTSD often have depression resistant to pharmacological therapies and present with additional comorbidities. These disorders…
Engineering Medicine Military Medicine Neuroscience

Visual Prosthetics for Vision Restoration for Retinal Degeneration

Paras Gupta Background: Retinal degeneration is initially associated with functional deficit and neuronal network programming that progresses to structural changes and heavy photoreceptor loss. After significant photoreceptor loss, innovative solutions such as neuroprotection, gene therapy, and cell therapy are no longer useful alone. Objectives: We explore visual prosthetics as an…
Engineering Medicine Ophthalmology

GLP-1R Agonists in the Treatment of Diabetes Mellitus: Reducing Serious Comorbidities

W. Marshall Fettig Background: Type 2 Diabetes Mellitus (T2DM) is a major health problem worldwide, characterized by persistent hyperglycemia, and associated with both long and short-term complications. T2DM affects approximately 374 million adults aged 20-79 worldwide,1 and its impact on the US economy was estimated at $327 billion in 2017.2…
Endocrinology Engineering Medicine

Mechanism of Action and Comparative Clinical Efficacies of Chemotherapy and Anti-PD-1 Immunotherapy for Patients with PD-L1 Expressing Non-Small Cell Lung Cancer

Sujay Shankar Background: Lung cancer is the second most common type of cancer and the deadliest cancer type in the U.S and worldwide. Non-small cell lung cancer (NSCLC) constitutes about 80-85% of all lung cancers and only has a 7% five-year survival rate if metastatic.1,2 Immunotherapy, specifically anti-PD-1 antibody drugs,…
Cancer Engineering Medicine

Meg3 (LncRNA) Knockdown as a Target for the Treatment of Post-Traumatic, Corneal Neovascularization

Ronald Alek Sperry Backgound: Corneal neovascularization is a condition characterized by ingrowth of blood vessels into the corneal tissue. Currently, treatment is progression-dependent because immature blood vessels depend on growth factors for proliferation while established blood vessels do not. This dictates that treatment be aimed at either the removal of…
Engineering Medicine Ophthalmology

Visual Inspection with Acetic Acid (VIA) Screening for Cervical Cancer Potentially has Higher Sensitivity than Cervical Cytology

Mounir Khatib Background. More than one-half a million women are diagnosed worldwide with cervical cancer annually. Of the approximately 270,000 cervical cancer-related deaths in 2015, 90% were from low-income and middle-income countries (LMIC). Screening methods include the Papanicolaou Smear (Pap Smear), which requires the harvesting of cervical cells (including the…
Cancer Engineering Medicine